EPOETIN ALFA
Presentation: 10 vials of solution for injection, with a dose of 1ml each, in 2000 IU, 4000 IU, and 10,000 IU presentations.
Used for the treatment of Chronic kidney disease (CKD), Anemia associated with non-myeloid cancer, and Secondary to myelosuppressive chemotherapy.

RITUXIMAB
Presentation: 100 and 500 mg injectables (via vials of 10mL and 50mL).
Used for the treatment of Rheumatoid arthritis, Granulomatosis with polyangiitis, and Microscopic Polyangiitis.